ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 111 filers reported holding ACORDA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 33.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,000 | -27.3% | 16,621 | +51.3% | 0.00% | – |
| Q4 2019 | $22,000 | -31.2% | 10,987 | 0.0% | 0.00% | – |
| Q3 2019 | $32,000 | -61.9% | 10,987 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $84,000 | -42.5% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $146,000 | -14.6% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $171,000 | -20.8% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $216,000 | -31.4% | 10,987 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $315,000 | +21.2% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $260,000 | +10.2% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $236,000 | -9.2% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $260,000 | +20.4% | 10,987 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $216,000 | -96.5% | 10,987 | -96.3% | 0.00% | -95.7% |
| Q1 2017 | $6,239,000 | +4.0% | 297,099 | -6.9% | 0.05% | -2.1% |
| Q4 2016 | $5,999,000 | -10.0% | 319,099 | 0.0% | 0.05% | -11.1% |
| Q3 2016 | $6,663,000 | -18.1% | 319,099 | 0.0% | 0.05% | -19.4% |
| Q2 2016 | $8,139,000 | -3.6% | 319,099 | -0.0% | 0.07% | -4.3% |
| Q1 2016 | $8,442,000 | -25.1% | 319,162 | +21.2% | 0.07% | -26.3% |
| Q4 2015 | $11,269,000 | +144.2% | 263,408 | +51.3% | 0.10% | +131.7% |
| Q3 2015 | $4,615,000 | -13.3% | 174,100 | +9.0% | 0.04% | -6.8% |
| Q2 2015 | $5,325,000 | +0.2% | 159,764 | 0.0% | 0.04% | 0.0% |
| Q1 2015 | $5,317,000 | +932.4% | 159,764 | +1168.0% | 0.04% | +1000.0% |
| Q4 2014 | $515,000 | +20.6% | 12,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $427,000 | -18.7% | 12,600 | -19.1% | 0.00% | 0.0% |
| Q2 2014 | $525,000 | -11.0% | 15,566 | 0.0% | 0.00% | -20.0% |
| Q1 2014 | $590,000 | +29.7% | 15,566 | 0.0% | 0.01% | +25.0% |
| Q4 2013 | $455,000 | -14.8% | 15,566 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $534,000 | +3.9% | 15,566 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $514,000 | – | 15,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |